Taysha Gene Therapies, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $160.4M
Liabilities Breakdown FY2024
Total Liabilities: $88.8M
Asset Breakdown
Total Assets: $160.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $139.0M | 86.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $7.5M | 4.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $13.8M | 8.6% |
Liabilities Breakdown
Total Liabilities: $88.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.6M | 4.0% |
| Long-Term Debt | $43.9M | 49.5% |
| Other Liabilities | $41.3M | 46.5% |